Results Healthcare advises Creativ-Ceutical on its acquisition by Huntsworth plc

  • Service: M&A
  • Sector: Healthcare
  • Sub Sector: Pharma Commercialisation Services
  • Engagement Type: Sell Side
May 2019
has been acquired by

Results Healthcare is delighted to have been the exclusive financial advisor to the shareholders of Creativ-Ceutical on its acquisition by Huntsworth plc, further cementing our position as a global advisor to leading healthcare and life sciences companies.

Huntsworth plc, the healthcare and communications group announces the acquisition of 70% of Creativ-Ceutical S.A.R.L., a Luxembourg company, from 100% shareholder Avicenne Invest S.A., a family investment company connected to Creativ-Ceutical’s founder Prof. Mondher Toumi for a maximum aggregate consideration of €75 million.

Creativ-Ceutical is a strategic market access, health economics and outcomes research consultancy. The business will sit within Huntsworth’s medical division and will continue to be led by founder Prof. Mondher Toumi, one of the global leading experts in this increasingly strategic important area in the development of new drugs. The business is headquartered in Luxembourg with principal operating units in Poland, Tunisia and France and serves global pharmaceutical and biotech clients as well as governmental organisations including the World Bank and the EU Commission.

Results have been outstanding throughout the process and I cannot recommend them highly enough! They are a smart team of genuine sector experts that are impressive with their craft and showed relentless commitment to delivering the best outcome possible. I am extremely happy with the team and the outcome they have achieved.

Prof. Mondher Toumi

President & CEO, Creativ-Ceutical

Sector Related Deals

Aug 2021
a Sovereign Capital Partners-backed company
has acquired
Aug 2021
a Sovereign Capital Partners-backed company
has acquired
Jun 2021
has been acquired by
Apr 2021
has invested in
Mar 2021
has invested in
Jun 2020
has been acquired by
Jun 2020
has been acquired by
Oct 2019
has acquired
Oct 2019
US division
US division, has been acquired by